| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP1-18651-0.02mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2737-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2618SS | |||
| Azide and BSA Free | NBP2-80817 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47909-0.1mg | |||
| IHC-Prediluted | NBP2-48362 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB110-58780SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47663-0.1mg | |||
| IHC-Prediluted | NBP2-48194 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-33321-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB110-58778SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-47178SS | |||
![Western Blot: ER alpha/NR3A1 Antibody (OTI1B1) - Azide and BSA Free [NBP2-70687] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Estrogen Receptor alpha (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with ant](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-OTI1B1-Azide-and-BSA-Free-Western-Blot-NBP2-70687-img0001.jpg "Western Blot: ER alpha/NR3A1 Antibody (OTI1B1) - Azide and BSA Free [NBP2-70687] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Estrogen Receptor alpha (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with ant")
![Immunohistochemistry: ER alpha/NR3A1 Antibody (OTI1B1) - Azide and BSA Free [NBP2-70687] - Staining of paraffin-embedded Human prostate tissue using anti-Estrogen Receptor alpha mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-OTI1B1-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70687-img0008.jpg)
![Immunohistochemistry: ER alpha/NR3A1 Antibody (OTI1B1) - Azide and BSA Free [NBP2-70687] - Staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-Estrogen Receptor alpha mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-OTI1B1-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70687-img0002.jpg)
![Immunohistochemistry: ER alpha/NR3A1 Antibody (OTI1B1) - Azide and BSA Free [NBP2-70687] - Staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-Estrogen Receptor alpha mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-OTI1B1-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70687-img0003.jpg)
![Immunohistochemistry: ER alpha/NR3A1 Antibody (OTI1B1) - Azide and BSA Free [NBP2-70687] - Staining of paraffin-embedded Human breast tissue using anti-Estrogen Receptor alpha mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-OTI1B1-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70687-img0004.jpg)
![Immunohistochemistry: ER alpha/NR3A1 Antibody (OTI1B1) - Azide and BSA Free [NBP2-70687] - Staining of paraffin-embedded Human Kidney tissue using anti-Estrogen Receptor alpha mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-OTI1B1-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70687-img0005.jpg)
![Immunohistochemistry: ER alpha/NR3A1 Antibody (OTI1B1) - Azide and BSA Free [NBP2-70687] - Staining of paraffin-embedded Human lymphoma tissue using anti-Estrogen Receptor alpha mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-OTI1B1-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70687-img0006.jpg)
![Immunohistochemistry: ER alpha/NR3A1 Antibody (OTI1B1) - Azide and BSA Free [NBP2-70687] - Staining of paraffin-embedded Human pancreas tissue using anti-Estrogen Receptor alpha mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-OTI1B1-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70687-img0007.jpg)
![Immunohistochemistry: ER alpha/NR3A1 Antibody (OTI1B1) - Azide and BSA Free [NBP2-70687] - Staining of paraffin-embedded Human tonsil using anti-Estrogen Receptor alpha mouse monoclonal antibody.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-OTI1B1-Azide-and-BSA-Free-Immunohistochemistry-NBP2-70687-img0009.jpg)
![Immunohistochemistry: VEGFR3/Flt-4 Antibody (9D9) [NBP1-18651] - Saphenous vein wall harvested from a patient diagnosed with triple-vessel CAD. Histological sections of a graft wall obtained from a 71-year-old patient who developed early graft failure 11 months after coronary artery bypass grafting. VEGFR-3 (b) is shown to be expressed by immunohistochemical staining in smooth muscle cells of the tunica media (TM) and is strongly present in endothelial cells of the tunica intima (TI). Image collected and cropped by CiteAb from the following publication (//link.springer.com/10.1007/s00380-018-1158-9) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/VEGFR3-Flt-4-Antibody-9D9-Immunohistochemistry-NBP1-18651-img0011.jpg "Immunohistochemistry: VEGFR3/Flt-4 Antibody (9D9) [NBP1-18651] - Saphenous vein wall harvested from a patient diagnosed with triple-vessel CAD. Histological sections of a graft wall obtained from a 71-year-old patient who developed early graft failure 11 months after coronary artery bypass grafting. VEGFR-3 (b) is shown to be expressed by immunohistochemical staining in smooth muscle cells of the tunica media (TM) and is strongly present in endothelial cells of the tunica intima (TI). Image collected and cropped by CiteAb from the following publication (//link.springer.com/10.1007/s00380-018-1158-9) licensed under a CC-BY license.")
![Western Blot: VEGFR3/Flt-4 Antibody (9D9) [NBP1-18651] - Analysis using recombinant human soluble VEGF Receptor 3 as target.](http://images.novusbio.com/fullsize/VEGFR3-Flt-4-Antibody-9D9-Western-Blot-NBP1-18651-img0010.jpg)
![Flow Cytometry: VEGFR3/Flt-4 Antibody (9D9) [NBP1-18651] - Fig. 1: Flow analysis of VEGFR-3/FLT4 expression in primary human dermal lymphatic endothelial cells (HDLEC).](http://images.novusbio.com/fullsize/VEGFR3-Flt-4-Antibody-9D9-Flow-Cytometry-NBP1-18651-img0007.jpg)
![Flow Cytometry: VEGFR3/Flt-4 Antibody (9D9) [NBP1-18651] - Fig. 1: Flow analysis of VEGFR-3/FLT4 expression in primary human dermal mivrovascular endothelial cells (HDMVEC) and human umbilical vein endothelial cells (HUVEC). There is only a very weak expression of VEGFR-3/FLT4 detectable in the HUVECs but a strong one in the HDMVEC.](http://images.novusbio.com/fullsize/VEGFR3-Flt-4-Antibody-9D9-Flow-Cytometry-NBP1-18651-img0006.jpg)
![Immunohistochemistry: VEGFR3/Flt-4 Antibody (9D9) - Azide and BSA Free [NBP1-18651] - Saphenous vein wall harvested from a patient diagnosed with double-vessel CAD showing immunohistochemical staining. VEGF-C (a) & VEGFR-3 (b) reactivity in a graft wall obtained from a 67-year-old patient who developed the early graft restenosis within 7 months after coronary artery bypass grafting (the same patient as mentioned in Fig. 6). VEGF-C is localized exclusively within individual smooth muscle cells of the tunica media (TM). Cells with positive VEGFR-3 expression are situated in endothelial cells of the tunica intima (TI). c Negative control. TA tunica adventitia Image collected & cropped by CiteAb from the following publication (//link.springer.com/10.1007/s00380-018-1158-9), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-18651_mouse-monoclonal-vegfr3-flt-4-antibody-9d9-310202415363714.jpg)
![Immunohistochemistry: VEGFR3/Flt-4 Antibody (9D9) - Azide and BSA Free [NBP1-18651] - Immunohistochemical staining of an internal thoracic artery & saphenous vein wall harvested from a patient with no evidence of luminal stenosis 12Â months after CABG. Immunohistochemical staining of VEGF-C (a) & CAV2 (b) in an internal thoracic artery (ITA) graft & VEGFR-3 (c) in saphenous vein (SV) transplant harvested from a 65-year-old patient diagnosed with triple-vessel CAD. Note that lack of CAV2 expression within smooth muscle cells (SMC) in ITA wall is accompanied by VEGF-C positive expression in the same area. In SV tissue sample harvested from the same patient, no VEGRR-3 expression was found. d Negative control. TI tunica intima, TM tunica media, TA tunica adventitia Image collected & cropped by CiteAb from the following publication (//link.springer.com/10.1007/s00380-018-1158-9), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp1-18651_mouse-monoclonal-vegfr3-flt-4-antibody-9d9-310202415394521.jpg)
![Immunohistochemistry: PD-ECGF/Thymidine Phosphorylase Antibody (PGF 44C) [NB100-2737] - Immunohistochemical staining of thymidine phosphorylase (TP) expression and related markers in benign lymph node. In benign lymph node, TP expression highlights the meshwork of macrophages (arrow in inset; 400x) and endothelial cells (arrowhead in inset; 400x). Images are from an Olympus BX41 microscope (Olympus Corp., Tokyo, Japan) processed with Qcapture Pro 5.1 (QImaging, Surrey, BC, Canada). Image collected and cropped by CiteAb from the following publication (//www.hindawi.com/journals/ah/2011/875135/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/PD-ECGF-Thymidine-Phosphorylase-Antibody-PGF-44C-Immunohistochemistry-NB100-2737-img0003.jpg "Immunohistochemistry: PD-ECGF/Thymidine Phosphorylase Antibody (PGF 44C) [NB100-2737] - Immunohistochemical staining of thymidine phosphorylase (TP) expression and related markers in benign lymph node. In benign lymph node, TP expression highlights the meshwork of macrophages (arrow in inset; 400x) and endothelial cells (arrowhead in inset; 400x). Images are from an Olympus BX41 microscope (Olympus Corp., Tokyo, Japan) processed with Qcapture Pro 5.1 (QImaging, Surrey, BC, Canada). Image collected and cropped by CiteAb from the following publication (//www.hindawi.com/journals/ah/2011/875135/) licensed under a CC-BY license.")
![Immunohistochemistry: PD-ECGF/Thymidine Phosphorylase Antibody (PGF 44C) [NB100-2737] - Immunohistochemical staining of thymidine phosphorylase (TP) expression and related markers in benign lymph node in lymph node with malignant mycosis fungoides/Sezary syndrome cells (LN-MF). CD21 is negative in this case of LN-MF. Images are from an Olympus BX41 microscope (Olympus Corp., Tokyo, Japan) processed with Qcapture Pro 5.1 (QImaging, Surrey, BC, Canada). Image collected and cropped by CiteAb from the following publication (//www.hindawi.com/journals/ah/2011/875135/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/PD-ECGF-Thymidine-Phosphorylase-Antibody-PGF-44C-Immunohistochemistry-NB100-2737-img0008.jpg)
![Immunohistochemistry: PD-ECGF/Thymidine Phosphorylase Antibody (PGF 44C) [NB100-2737] - Immunohistochemical staining of thymidine phosphorylase (TP) expression and related markers in benign lymph node in lymph node with malignant mycosis fungoides/Sezary syndrome cells (LN-MF). LN-MF: hematoxylin and eosin (H&E) stain. Images are from an Olympus BX41 microscope (Olympus Corp., Tokyo, Japan) processed with Qcapture Pro 5.1 (QImaging, Surrey, BC, Canada). Image collected and cropped by CiteAb from the following publication (//www.hindawi.com/journals/ah/2011/875135/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/PD-ECGF-Thymidine-Phosphorylase-Antibody-PGF-44C-Immunohistochemistry-NB100-2737-img0004.jpg)
![Immunohistochemistry: PD-ECGF/Thymidine Phosphorylase Antibody (PGF 44C) [NB100-2737] - Immunohistochemical staining of thymidine phosphorylase (TP) expression and related markers in benign lymph node in lymph node with malignant mycosis fungoides/Sezary syndrome cells (LN-MF). CD3 highlights the malignant T cells and reactive T cells in LN-MF. Images are from an Olympus BX41 microscope (Olympus Corp., Tokyo, Japan) processed with Qcapture Pro 5.1 (QImaging, Surrey, BC, Canada). Image collected and cropped by CiteAb from the following publication (//www.hindawi.com/journals/ah/2011/875135/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/PD-ECGF-Thymidine-Phosphorylase-Antibody-PGF-44C-Immunohistochemistry-NB100-2737-img0005.jpg)
![Immunohistochemistry: PD-ECGF/Thymidine Phosphorylase Antibody (PGF 44C) [NB100-2737] - Immunohistochemical staining of thymidine phosphorylase (TP) expression and related markers in benign lymph node in lymph node with malignant mycosis fungoides/Sezary syndrome cells (LN-MF). CD4 is weakly expressed in the malignant T cells in LN-MF. Images are from an Olympus BX41 microscope (Olympus Corp., Tokyo, Japan) processed with Qcapture Pro 5.1 (QImaging, Surrey, BC, Canada). Image collected and cropped by CiteAb from the following publication (//www.hindawi.com/journals/ah/2011/875135/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/PD-ECGF-Thymidine-Phosphorylase-Antibody-PGF-44C-Immunohistochemistry-NB100-2737-img0006.jpg)
![Immunohistochemistry: PD-ECGF/Thymidine Phosphorylase Antibody (PGF 44C) [NB100-2737] - Immunohistochemical staining of thymidine phosphorylase (TP) expression and related markers in benign lymph node in lymph node with malignant mycosis fungoides/Sezary syndrome cells (LN-MF). CD68 highlights the macrophages in LN-MF. Images are from an Olympus BX41 microscope (Olympus Corp., Tokyo, Japan) processed with Qcapture Pro 5.1 (QImaging, Surrey, BC, Canada). Image collected and cropped by CiteAb from the following publication (//www.hindawi.com/journals/ah/2011/875135/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/PD-ECGF-Thymidine-Phosphorylase-Antibody-PGF-44C-Immunohistochemistry-NB100-2737-img0007.jpg)
![Immunohistochemistry: PD-ECGF/Thymidine Phosphorylase Antibody (PGF 44C) [NB100-2737] - Immunohistochemical staining of thymidine phosphorylase (TP) expression and related markers in benign lymph node in lymph node with malignant mycosis fungoides/Sezary syndrome cells (LN-MF). TP highlights the macrophages (cytoplasmic/nuclear pattern, arrowhead in inset 1; 400x) and the malignant T cells (cytoplasmic pattern, arrow in inset 2; 400x) in a cytoplasmic staining pattern. Multiple mitotic figures are also noted in the malignant T cells. Images are from an Olympus BX41 microscope (Olympus Corp., Tokyo, Japan) processed with Qcapture Pro 5.1 (QImaging, Surrey, BC, Canada). Image collected and cropped by CiteAb from the following publication (//www.hindawi.com/journals/ah/2011/875135/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/PD-ECGF-Thymidine-Phosphorylase-Antibody-PGF-44C-Immunohistochemistry-NB100-2737-img0009.jpg)
![Immunocytochemistry/Immunofluorescence: Integrin alpha V/CD51 Antibody (P2W7) [NB100-2618] - HeLa cells were fixed in 4% paraformaldehyde for 10 minutes and permeabilized in 0.05% Triton X-100 in PBS for 5 minutes. The cells were incubated with Integrin alpha V/CD51 Antibody [P2W7] (NB100-2618) at 1 ug/ml overnight at 4C and detected with an anti-mouse Dylight 488 (Green) at a 1:1000 dilution for 60 minutes. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.](http://images.novusbio.com/fullsize/Integrin-alpha-V-CD51-Antibody-P2W7-Immunocytochemistry-Immunofluorescence-NB100-2618-img0001.jpg "Immunocytochemistry/Immunofluorescence: Integrin alpha V/CD51 Antibody (P2W7) [NB100-2618] - HeLa cells were fixed in 4% paraformaldehyde for 10 minutes and permeabilized in 0.05% Triton X-100 in PBS for 5 minutes. The cells were incubated with Integrin alpha V/CD51 Antibody [P2W7] (NB100-2618) at 1 ug/ml overnight at 4C and detected with an anti-mouse Dylight 488 (Green) at a 1:1000 dilution for 60 minutes. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.")
![Immunohistochemistry: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Representative images of RCC patient biopsies immunostained for VEGFR2, CD34, and NRP1 and counterstained using Hoechst33342. Left column shows examples of NRP1 expressed by endothelial cells; middle column shows a tumor sample with low NRP1 expression. Right column shows NRP1 positive perivascular tumor cells. Blood vessels were stained for CD34 and nuclei counterstained using Hoechst33342. Left column shows cis complexes, localized within the endothelium. Middle column shows a tumor lacking VEGFR2/NRP1 complexes. Right column shows trans complexes, located adjacent to the endothelium (white arrowheads). Image collected and cropped by Citeab from the following publication (Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma. J Pathol (2020) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-NBP2-44567-img0005.jpg "Immunohistochemistry: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Representative images of RCC patient biopsies immunostained for VEGFR2, CD34, and NRP1 and counterstained using Hoechst33342. Left column shows examples of NRP1 expressed by endothelial cells; middle column shows a tumor sample with low NRP1 expression. Right column shows NRP1 positive perivascular tumor cells. Blood vessels were stained for CD34 and nuclei counterstained using Hoechst33342. Left column shows cis complexes, localized within the endothelium. Middle column shows a tumor lacking VEGFR2/NRP1 complexes. Right column shows trans complexes, located adjacent to the endothelium (white arrowheads). Image collected and cropped by Citeab from the following publication (Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma. J Pathol (2020) licensed under a CC-BY license.")
![Immunohistochemistry-Paraffin: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Human Angiosarcoma stained with CD34 Monoclonal Antibody (QBEnd/10 + HPCA1/763)](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-Paraffin-NBP2-44567-img0001.jpg)
![Immunohistochemistry-Paraffin: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Human Colon Carcinoma stained with CD34 Monoclonal Antibody (QBEnd/10 + HPCA1/763)](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-Paraffin-NBP2-44567-img0002.jpg)
![Immunohistochemistry-Paraffin: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Human Placenta stained with CD34 Monoclonal Antibody (QBEnd/10 + HPCA1/763)](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-Paraffin-NBP2-44567-img0003.jpg)
![Immunohistochemistry-Paraffin: CD34 Antibody (QBEnd/10 + HPCA1/763) [NBP2-44567] - Human Tonsil stained with CD34 Monoclonal Antibody (QBEnd/10 + HPCA1/763)](http://images.novusbio.com/fullsize/CD34-Antibody-QBEnd-10-+-HPCA1-763-Immunohistochemistry-Paraffin-NBP2-44567-img0004.jpg)
![Western Blot: Robo4 Antibody [NB110-58780] - Detection of ROBO4 in HUVEC lysate.](http://images.novusbio.com/fullsize/Robo4-Antibody-Western-Blot-NB110-58780-img0005.jpg "Western Blot: Robo4 Antibody [NB110-58780] - Detection of ROBO4 in HUVEC lysate.")
![Immunocytochemistry/Immunofluorescence: Robo4 Antibody [NB110-58780] - Robo4 antibody was tested in Huvec cells with Dylight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).](http://images.novusbio.com/fullsize/Robo4-Antibody-Immunocytochemistry-Immunofluorescence-NB110-58780-img0006.jpg)
![Immunohistochemistry: Robo4 Antibody [NB110-58780] - Detection of ROBO4 in human placental epithelial cells and trophoblasts.](http://images.novusbio.com/fullsize/Robo4-Antibody-Immunohistochemistry-NB110-58780-img0004.jpg)
![Immunohistochemistry-Paraffin: Actin (Muscle Specific) Antibody (HHF35 + MSA/953) [NBP2-45275] - Rat Stomach stained with Muscle Specific Actin Monoclonal Antibody (HHF35 + MSA/953)](http://images.novusbio.com/fullsize/Actin-Muscle-Specific-Antibody-HHF35-+-MSA-953-Immunohistochemistry-Paraffin-NBP2-45275-img0005.jpg "Immunohistochemistry-Paraffin: Actin (Muscle Specific) Antibody (HHF35 + MSA/953) [NBP2-45275] - Rat Stomach stained with Muscle Specific Actin Monoclonal Antibody (HHF35 + MSA/953)")
![Immunohistochemistry-Paraffin: Actin (Muscle Specific) Antibody (HHF35 + MSA/953) [NBP2-45275] - Human Leiomyosarcoma stained with Muscle Specific Actin Monoclonal Antibody (HHF35 + MSA/953)](http://images.novusbio.com/fullsize/Actin-Muscle-Specific-Antibody-HHF35-+-MSA-953-Immunohistochemistry-Paraffin-NBP2-45275-img0001.jpg)
![Immunohistochemistry-Paraffin: Actin (Muscle Specific) Antibody (HHF35 + MSA/953) [NBP2-45275] - Human Rhabdomyosarcoma stained with Muscle Specific Actin Monoclonal Antibody (HHF35 + MSA/953)](http://images.novusbio.com/fullsize/Actin-Muscle-Specific-Antibody-HHF35-+-MSA-953-Immunohistochemistry-Paraffin-NBP2-45275-img0002.jpg)
![Immunohistochemistry-Paraffin: Actin (Muscle Specific) Antibody (HHF35 + MSA/953) [NBP2-45275] - Rat Heart stained with Muscle Specific Actin Monoclonal Antibody (HHF35 + MSA/953)](http://images.novusbio.com/fullsize/Actin-Muscle-Specific-Antibody-HHF35-+-MSA-953-Immunohistochemistry-Paraffin-NBP2-45275-img0003.jpg)
![Immunohistochemistry-Paraffin: Actin (Muscle Specific) Antibody (HHF35 + MSA/953) [NBP2-45275] - Rat Lung stained with Muscle Specific Actin Monoclonal Antibody (HHF35 + MSA/953)](http://images.novusbio.com/fullsize/Actin-Muscle-Specific-Antibody-HHF35-+-MSA-953-Immunohistochemistry-Paraffin-NBP2-45275-img0004.jpg)
![Western Blot: ER alpha/NR3A1 Antibody (ER506) [NBP2-33320] - Western Blot Analysis of human MCF-7 cell lysate using ER alpha/NR3A1 Antibody (ER506).](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-ER506-Western-Blot-NBP2-33320-img0017.jpg "Western Blot: ER alpha/NR3A1 Antibody (ER506) [NBP2-33320] - Western Blot Analysis of human MCF-7 cell lysate using ER alpha/NR3A1 Antibody (ER506).")
![Immunohistochemistry-Paraffin: ER alpha/NR3A1 Antibody (ER506) [NBP2-33320] - Formalin-fixed, paraffin-embedded human Endometrium stained with ER alpha/NR3A1 Antibody (ER506).](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-ER506-Immunohistochemistry-Paraffin-NBP2-33320-img0015.jpg)
![Flow Cytometry: ER alpha/NR3A1 Antibody (ER506) [NBP2-33320] - Flow Cytometry for human ER-alpha on MCF-7 cells. Black: cells alone; Green: Isotype Control; Red: PE-labeled ER alpha/NR3A1 antibody (ER506).](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-ER506-Flow-Cytometry-NBP2-33320-img0018.jpg)
![Simple Western: ER alpha/NR3A1 Antibody (ER506) [NBP2-33320] - Simple Western lane view shows a specific band for Estrogen Receptor in 0.2 mg/ml of MCF-7 (left) and T47D (right) lysate(s). This experiment was performed under reducing conditions using the 12-230 kDa separation system.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-ER506-Simple-Western-NBP2-33320-img0007.jpg)
![Simple Western: ER alpha/NR3A1 Antibody (ER506) [NBP2-33320] - Electropherogram image of the corresponding Simple Western lane. Estrogen Receptor antibody was used at 10 ug/ml dilution of MCF-7 and T47D lysates(s) respectively.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-ER506-Simple-Western-NBP2-33320-img0009.jpg)
![Protein Array: ER alpha/NR3A1 Antibody (ER506) [NBP2-33320] - Analysis of Protein Array containing more than 19,000 full-length human proteins using ER alpha/NR3A1 Antibody (ER506). Z- and S- Score: The Z-score represents the strength of a signal that a monoclonal antibody (MAb) (in combination with a fluorescently-tagged anti-IgG secondary antibody) produces when binding to a particular protein on the HuProt(TM) array. Z-scores are described in units of standard deviations (SD?s) above the mean value of all signals generated on that array. If targets on HuProt(TM) are arranged in descending order of the Z-score, the S-score is the difference (also in units of SD?s) between the Z-score. S-score therefore represents the relative target specificity of a MAb to its intended target. A MAb is considered to specific to its intended target, if the MAb has an S-score of at least 2.5.](http://images.novusbio.com/fullsize/ER-alpha-NR3A1-Antibody-ER506-Protein-Array-NBP2-33320-img0016.jpg)
![Western Blot: Robo4 Antibody [NB110-58778] - Detection of ROBO4 in HUVEC lysate](http://images.novusbio.com/fullsize/Robo4-Antibody-Western-Blot-NB110-58778-img0003.jpg "Western Blot: Robo4 Antibody [NB110-58778] - Detection of ROBO4 in HUVEC lysate")
![Immunocytochemistry/Immunofluorescence: Robo4 Antibody [NB110-58778] - Robo4 antibody was tested in Huvec cells with Dylight 488 (green). Nuclei and alpha-tubulin were counterstained with DAPI (blue) and Dylight 550 (red).](http://images.novusbio.com/fullsize/Robo4-Antibody-Immunocytochemistry-Immunofluorescence-NB110-58778-img0004.jpg)
![Immunohistochemistry: Robo4 Antibody [NB110-58778] - Detection of ROBO4 in endothelium and trophoblasts of the placenta.](http://images.novusbio.com/fullsize/Robo4-Antibody-Immunohistochemistry-NB110-58778-img0002.jpg)
![Western Blot: HIF-1 alpha Antibody - Exon 9 [NBP1-47178] - Human recombinant HIF-1 alpha protein.](http://images.novusbio.com/fullsize/HIF-1-alpha-Exon-9-Antibody-exon-9-Western-Blot-NBP1-47178-img0002.jpg "Western Blot: HIF-1 alpha Antibody - Exon 9 [NBP1-47178] - Human recombinant HIF-1 alpha protein.")
![Western Blot: FGF R1 [p Tyr651, p Tyr652] Antibody [NBP2-24462] - Analysis of FGFR phosphoin recombinant fusion protein containing 1) phosphorylated tyrosine residues at positions 651 and 652 and 2) unphosphorylated tyrosine residues at positions 651 and 652, using FGFR phospho antibody at 0.002 ug/ml. Goat anti-rabbit IgG HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/FGF-R1-[p-Tyr651--p-Tyr652]-Antibody-Western-Blot-NBP2-24462-img0005.jpg "Western Blot: FGF R1 [p Tyr651, p Tyr652] Antibody [NBP2-24462] - Analysis of FGFR phosphoin recombinant fusion protein containing 1) phosphorylated tyrosine residues at positions 651 and 652 and 2) unphosphorylated tyrosine residues at positions 651 and 652, using FGFR phospho antibody at 0.002 ug/ml. Goat anti-rabbit IgG HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![Immunohistochemistry-Paraffin: FGF R1 [p Tyr651, p Tyr652] Antibody [NBP2-24462] - Analysis of FGFR1 phospho in formalin-fixed, paraffin-embedded human breast tumor tissue using an isotype control antibody (top left) and FGFR1 phospho antibody (bottom left, right) at 5 ug/ml.](http://images.novusbio.com/fullsize/FGF-R1-[p-Tyr651--p-Tyr652]-Antibody-Immunohistochemistry-Paraffin-NBP2-24462-img0004.jpg)